Boswellia supplements are generally well tolerated in clinical trials, with most side effects limited to mild digestive complaints like acid reflux or nausea. Across multiple randomized studies lasting up to 90 days, serious adverse events have been rare, and lab markers for liver, kidney, and blood health have typically stayed within normal ranges. That said, the safety picture is not as simple as “it’s just an herb.” There are meaningful drug interactions, population-specific risks, and at least one documented case of serious organ injury worth knowing about before you start taking it.
Digestive Complaints Are the Most Frequently Reported Problem
If boswellia gives you trouble, you’ll most likely feel it in your stomach. In clinical trials of boswellia extract for osteoarthritis, the most commonly noted adverse effects were minor gastrointestinal issues, and some trials reported no significant adverse events at all.1PubMed. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial A 90-day placebo-controlled trial of two proprietary boswellia formulations found that safety parameters were essentially unchanged from placebo, with the only reported adverse event being acidity in one participant out of each group.2PubMed Central. Comparative Efficacy and Tolerability of 5-Loxin® and Aflapin® Against Osteoarthritis of the Knee: A Double Blind, Randomized, Placebo Controlled Clinical Study Another randomized trial of a boswellia-based combination product for knee osteoarthritis found zero adverse effects over 90 days based on clinical exams, blood work, and ECG analysis, with 100 percent patient compliance unaffected by side effects.3PubMed Central. Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial
This is a considerably milder side-effect profile than what you’d expect from conventional anti-inflammatory drugs. NSAIDs are associated with a high rate of gastrointestinal and cardiovascular adverse effects, and boswellia extracts are expected to offer better tolerability by comparison, though researchers have been careful to note that this needs confirmation in larger trials.4SpringerLink. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data The existing evidence is reassuring for short-to-medium-term use, but most studies have been modest in size and duration. Long-term safety data beyond a few months remains thin.
Drug Interactions Are a Real Concern
The side effect most likely to catch people off guard isn’t something boswellia does on its own. It’s what boswellia does to other drugs you might be taking. Extracts from multiple Boswellia species have been identified as potent, non-selective inhibitors of several major drug-metabolizing enzymes in the cytochrome P450 family, including CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4.5PubMed. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction These enzymes are responsible for breaking down a huge proportion of commonly prescribed medications, from blood thinners to antidepressants to statins to birth control pills.
When boswellia slows down these enzymes, the drugs that rely on them can build up in your bloodstream to higher levels than intended. This has been demonstrated concretely with metformin, a widely used diabetes drug. In animal studies, boswellic acids increased the peak blood concentration, total drug exposure, and half-life of metformin while decreasing its clearance. The result was a significantly stronger blood-sugar-lowering effect than metformin alone would produce, driven by inhibition of the CYP3A enzyme.6Journal of Pharmaceutical Research Science & Technology. Boswellic Acids Pretreatment Enhances the Bioavailability and Hypoglycemic Action of Metformin in Rats: Involvement of CYP3A Inhibition The researchers concluded that supplements containing boswellia should be used cautiously alongside metformin because of the risk of unexpectedly amplified drug effects.
This interaction principle extends well beyond metformin. If you take any prescription medication metabolized by the CYP enzymes listed above, adding a boswellia supplement could alter how much of that drug ends up active in your body. The practical takeaway: talk to your pharmacist or doctor before combining boswellia with prescription drugs, especially warfarin, certain anti-seizure medications, immunosuppressants, or other drugs with a narrow margin between a therapeutic dose and a dangerous one.
It Can Lower Blood Sugar and Lipids on Its Own
Beyond amplifying the effects of diabetes medications, boswellia appears to move blood sugar and blood lipid numbers on its own. A double-blind, placebo-controlled trial in patients with type 2 diabetes found that boswellia gum resin supplementation significantly reduced fasting blood sugar, hemoglobin A1c (a marker of long-term blood sugar control), and triglycerides compared to placebo.7PubMed Central. The Effects of Boswellia serrata Gum Resin on the Blood Glucose and Lipid Profile of Diabetic Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial
For someone specifically looking to help manage diabetes, this might sound like a benefit rather than a side effect. But if you’re not diabetic, or if you’re already taking medication that lowers your blood sugar, this property could push your levels too low. The combination of boswellia’s own glucose-lowering activity with its ability to boost the potency of drugs like metformin creates a double risk for hypoglycemia. If you notice unusual dizziness, shakiness, or lightheadedness after starting boswellia, blood sugar is worth checking.
Skin Reactions and Allergic Responses
Boswellia resin and its essential oil are core ingredients in frankincense, which is used widely in aromatherapy, skincare products, and incense. For most people this is harmless, but allergic contact dermatitis from Boswellia carterii (frankincense) oil has been documented.8PubMed. Allergic contact dermatitis from Boswellia carterii (frankincense) oil This is a delayed-type skin reaction, meaning it doesn’t happen on first contact but develops after repeated exposure sensitizes the immune system. Once it develops, even small amounts of the oil can trigger redness, itching, and blistering at the contact site.
This is more relevant to topical boswellia products and essential oils than to oral supplements, but it’s worth noting if you’re using frankincense oil on your skin regularly. Patch testing a small area before widespread use is a reasonable precaution, especially if you have a history of contact allergies to other plant-derived products.
One Case of Acute Kidney Injury
The most alarming individual report in the medical literature involves a 72-year-old woman who developed acute kidney injury after taking Boswellia serrata capsules for eight days to manage radiation necrosis. The researchers noted this was the first reported case of kidney injury associated with boswellia. Her symptoms resolved once she stopped the supplement and received emergency medical care.9PubMed. Acute Kidney Injury Associated With Boswellia serrata for Radiation Necrosis The authors suggested that high doses may have contributed to the problem and called for careful supervision when using boswellia, particularly in vulnerable patients.
A single case report does not mean boswellia routinely damages kidneys. In formal toxicology studies and clinical trials, kidney function markers have generally remained normal. But this case is worth keeping in mind if you’re older, if you already have impaired kidney function, or if you’re taking other drugs that stress the kidneys. It also reinforces that “natural” does not mean “risk-free at any dose.”
Pregnancy and Breastfeeding
The evidence here is sparse and mixed, which itself should be a caution flag. A systematic review of herbal medicines used by pregnant women in Asian countries classified frankincense (Boswellia sacra) as not harmful to the mother or fetus in moderate doses for mild ailments, but noted that the resin in high doses acts as an emmenagogue, meaning it stimulates uterine blood flow and contractions, and could potentially induce abortion.10PubMed Central. Safety classification of herbal medicines used among pregnant women in Asian countries: a systematic review A separate systematic review looking specifically at lipid-lowering herbs during pregnancy concluded bluntly that there is a lack of evidence on the safe use of boswellic acids during pregnancy and lactation.11PubMed Central. Use of lipid-lowering medicinal herbs during pregnancy: A systematic review on safety and dosage
The traditional use of frankincense by pregnant women in parts of the Middle East and South Asia does provide some observational reassurance at low doses, but no controlled trials have been conducted in pregnant or breastfeeding women. Until better data exists, most practitioners advise erring on the side of caution and avoiding boswellia supplements during pregnancy, particularly in higher doses or concentrated extract form.
Immune System Modulation Cuts Both Ways
Boswellia’s anti-inflammatory reputation comes from its genuine ability to modulate the immune system, but “modulation” is not always the same thing as “suppression.” The effects are dose-dependent and sometimes go in opposite directions. At lower doses, boswellic acids have been shown to enhance certain immune responses, boosting secondary antibody production and increasing the activity of infection-fighting white blood cells. At higher doses, the same compounds can suppress antibody production and inhibit immune cell proliferation.12PubMed. Modulation of the immune system by Boswellia serrata extracts and boswellic acids Boswellic acids also downregulate several pro-inflammatory signaling molecules, including TNF-alpha and several interleukins, which is the mechanism behind their benefit in conditions like rheumatoid arthritis, asthma, and inflammatory bowel disease.
Research on Boswellia sacra essential oil has shown it can alter the development and maturation of dendritic cells, a type of immune cell that plays a central role in initiating immune responses. This interference with dendritic cell maturation could theoretically be useful in autoimmune conditions and transplantation, but it also raises questions about whether long-term boswellia use could blunt immune surveillance in ways we don’t fully understand yet.13PubMed Central. Evaluation of immunomodulatory effects of Boswellia sacra essential oil on T-cells and dendritic cells
For most healthy people using boswellia short-term for joint pain or inflammation, these immune effects are unlikely to cause problems. But if you have an autoimmune condition, are on immunosuppressive therapy, or are fighting an active infection, the way boswellia pushes and pulls the immune system adds a layer of unpredictability. Discuss it with your doctor rather than layering it on top of existing immune-modulating medications.
What Formal Toxicology Studies Show
For anyone worried about outright toxicity, the animal data is reassuring. Multiple formal safety assessments of boswellia extracts in rats have found no mortality or signs of toxicity at acute oral doses up to 2,000 mg per kilogram of body weight, the standard limit dose used in toxicology testing.14PubMed. Safety assessment of a novel water-soluble extract of Boswellia serrata gum resin: acute toxicity, 90-day sub-chronic toxicity, Ames’ bacterial reverse mutation, and in vivo micronucleus assays In 90-day repeated-dose studies, a water-soluble boswellia extract showed no adverse effects on body weight, food intake, organ weights, thyroid hormones, or any blood, tissue, or urinary parameters at the highest tested dose of 500 mg/kg/day. Genetic toxicity tests also came back clean.
A separate 28-day oral toxicity study of a standardized boswellia gum resin extract found no dose-related toxicity signs and established a no-observed-adverse-effect level of 1,000 mg/kg/day in both male and female rats.15PubMed. Toxicological Assessment of a Standardized Boswellia serrata Gum Resin Extract A third study testing a herbal combination formula containing boswellia similarly found no clinical signs of toxicity at the maximum tested dose of 2,000 mg/kg in acute testing and 1,000 mg/kg over 90 days of repeated dosing.16PubMed. Acute and sub chronic toxicity studies with herbal pain relieving formula (Rhuleave-K™) in rats
Translating rat doses directly to humans is never precise, but these margins are wide. The doses that caused no harm in animals are many times higher than what anyone would take as a supplement. This doesn’t mean unlimited doses are safe in humans, as the kidney injury case demonstrates, but it does suggest that typical supplement doses in the range of a few hundred milligrams per day are unlikely to cause direct organ toxicity in otherwise healthy people.
Liver Effects Appear Protective Rather Than Harmful
One organ that boswellia seems to help rather than hurt is the liver. In animal models of chemically induced liver damage, boswellia gum resin significantly reduced markers of liver injury, including the enzymes AST and ALT, and restored bilirubin, triglyceride, and albumin levels toward normal. The researchers attributed this to boswellia’s antioxidant, anti-inflammatory, and anti-fibrotic properties.17PubMed Central. Antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate gum resin in CCl4-induced hepatotoxicity Another study found that boswellia attenuated liver impairment caused by kidney ischemia-reperfusion injury in a dose-dependent fashion, with less tissue damage visible on histopathological examination.18PubMed. Repression of inflammatory pathways with Boswellia for alleviation of liver injury after renal ischemia reperfusion
These are animal studies, so drawing firm conclusions about liver safety in humans requires caution. But combined with clinical trial data showing that liver enzyme levels remain stable during boswellia supplementation, the overall picture suggests that boswellia is not a liver toxin and may even offer some degree of liver protection. This stands in contrast to several other herbal supplements, including kava and comfrey, which have well-documented hepatotoxicity risks.
Supplement Quality Varies More Than You’d Think
One underappreciated source of adverse effects from any herbal supplement isn’t the herb itself but what comes along with it. Heavy metal contamination is a concern across the herbal products market, and boswellia is not exempt from scrutiny. Analytical testing of traditional plant gums, including those in the Boswellia family, has found varying levels of metals like iron, potassium, and manganese across different species and sources.19Brazilian Journal of Biology. Contamination levels of toxic metals in selected traditional plants incense (gum) One analysis of Boswellia odorata leaf found no detectable lead or chromium, though manganese was relatively high compared to some other species tested.20Research Journal of Pure Science and Technology. Determination of Some Heavy Metals in Boswellia odorata, Thaumatococcus daniellii, Anogeissus leiocarpus, Erythrina senegalensis and Cochlospermum tinctorium Leaf
Contamination levels depend heavily on the geographic origin of the resin, soil conditions, and manufacturing practices. In countries without rigorous supplement regulation, finished boswellia products can vary dramatically in both active ingredient content and contaminant levels. Choosing products that have been third-party tested for purity by organizations like NSF, USP, or ConsumerLab adds a layer of protection that the boswellia itself cannot provide. If you’re experiencing side effects that seem out of proportion to what the clinical literature would predict, the problem may be with the product rather than the ingredient.
Bioavailability Differences Between Formulations
Not all boswellia supplements deliver the same amount of active compounds to your bloodstream, and this matters for the side-effect profile. Boswellic acids are poorly absorbed on their own due to their lipophilic nature, which is why manufacturers have developed enhanced formulations designed to improve bioavailability. Research on plasma levels in volunteers has found that even after taking nearly 800 mg of boswellia extract three times daily for 10 days, the plasma concentration of AKBA (one of the most pharmacologically active boswellic acids) peaked at only about 0.1 micromoles per liter. Another study found steady-state levels of just 0.04 micromoles per liter for AKBA, though a different boswellic acid, beta-BA, reached much higher levels of about 6.35 micromoles per liter due to its greater abundance in the extracts.21Journal of Traditional and Complementary Medicine. Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential
These numbers matter because enhanced-bioavailability formulations, such as those using lecithin complexes or nano-encapsulation, can deliver substantially more boswellic acid into circulation than traditional resin powder. Higher systemic exposure means a stronger therapeutic effect, but also amplifies the potential for drug interactions and the dose-dependent immune effects described above. If you’re switching from a basic boswellia powder to an enhanced formulation, you’re not just getting better absorption of the same product; you’re functionally increasing your dose, sometimes by a large margin. The side-effect profile you experienced with one formulation may not predict your experience with another.
Boswellia in Children and Cancer Patients
Boswellia supplements have been explored as adjunctive therapy for brain tumors and other cancers, in part because of their anti-inflammatory effects on brain swelling. However, laboratory research has raised a specific concern about pediatric brain tumors. One study investigating boswellic acid formulations against high-grade glioma cells found tumor-promoting potential at biologically relevant concentrations, leading the authors to conclude that these formulations are not suitable for treating pediatric high-grade glioma.22Journal of Traditional and Complementary Medicine. Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential This is a lab finding, not a clinical outcome, but it illustrates why using boswellia in cancer settings without medical guidance is risky. The same anti-inflammatory properties that seem helpful in one context can theoretically work against the body’s tumor surveillance in another.
For adults using boswellia to manage brain edema during radiation therapy, the kidney injury case discussed earlier adds another cautionary note. The patient in that report was taking boswellia specifically for radiation necrosis when she developed acute kidney injury. While radiation patients are often medically complex and on multiple treatments, combining boswellia with aggressive cancer therapies introduces variables that haven’t been studied in controlled settings. If you’re undergoing cancer treatment and considering boswellia, bring it up with your oncologist rather than self-prescribing.